Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study

Hormone Research

Volumn 64, Issue 6, 2005, Pages 293-298

  Appetecchia, M ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Benign nodular goiter; Computerized bone mineralometry; L Thyroxine; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CALCIUM; LEVOTHYROXINE; OSTEOCALCIN; PARATHYROID HORMONE; THYROTROPIN;

ADULT; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; BONE MINERAL; BONE REMODELING; CAUCASIAN; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; MAJOR CLINICAL STUDY; NODULAR GOITER; OSTEOPENIA; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL;

ADULT; BONE DENSITY; COHORT STUDIES; DENSITOMETRY, X-RAY; FEMALE; GOITER, NODULAR; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 28744441891     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089489     Document Type: Article

References (27)

1. Ross DS, Neer RM, Ridgway EC, Daniels GH: Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med 1987;82:1167-1170.
2. De Rosa G, Testa A, Giacomini D, Carrozza C, Astazi P, Caradonna P: Prospective study of bone loss in pre- and post-menopausal women on L-Thyroxine therapy for non toxic goitre. Clin Endocrinol (Oxf) 1997;47:529-535.
3. Greenspan SL, Greenspan FS: The effect of thyroid hormone on skeletal integrity. Ann Intern Med 1999;130:750-758.
4. Pantazi H, Papapetra PD: Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J Clin Endocrinol Metab 2000;88:1099-1106.
5. Mikosch P, Jauk B, Gallowitsch HJ, Pipam W, Kresnik E, Lind P: Suppressive levothyroxine therapy has no significant influence on bone degradation in women with thyroid carcinoma: a comparison with other disorders affecting bone metabolism. Thyroid 2001;11:257-263.
6. Vestergaard P, Rejnmark L, Weeke J, Mosekilde L: Fracture risk in patients treated for hyperthyroidism. Thyroid 2000;10:341-348.
7. Hadji P, Ilars O, Sturm G, Bauer T, Amons G, Schultz K: The effect of long-term, non suppressive levothyroxine treatment on quantitative ultrasonometry of bone in women. Eur J Endocrinol 2000;142:445-450.
8. Marcocci C, Golia F, Bruno-Bossio G, Vignali E, Pinchera A: Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J Clin Endocrinol Metab 1994;78: 816-817.
9. Guo CY, Weetman AP, Eastell R: Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine. Clin Endocrinol (Oxf) 1997;46:301-307.
10. Kisakol G, Kaya A, Gonen S, Tunc R: Bone and calcium metabolism in subclinical autoimmune hyperthyroidism and hypothyroidism. Endocr J 2003;50:657-661.
11. Lee MS, Kim SY, Loe MC, et al: Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J Clin Endocrinol Metab 1990;70:766-770.
12. Faber J, Jensen IW, Petersen L, Nygaard B, Hegedus L, Siersback-Nielsen K: Normalization of serum thyrotropin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women. Clin Endocrinol (Oxf) 1998;48:285-290.
13. Foldes J, Tarjan G, Szathmari M, Varga F, Krasznai I, Horvath C: Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis? Clin Endocrinol (Oxf) 1993;39:521-527.
14. Gurlek A, Gedik O: Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women. Thyroid 1999;9:539-543.
15. De Rosa G, Testa A, Maussier ML, Calla C, Astazi P, Albanese C: A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and post-menopausal women with nontoxic goitre. Horm Metab Res 1995;27:503-507.
16. Schindler AE: Thyroid function and post-menopause. Gynecol Endocrinol 2003;17:79-85.
17. Sijanovic S, Karner I: Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone. Medscape Womens Health 2001;6:3.
18. Ben-Shlomo A, Hagag P, Evans S, Weiss M: Early postmenopausal bone loss in hyperthyroidism. Maturitas 2001;39:19-27.
19. Diamond T, Nery L, Hales Y: A therapeutic dilemma: suppressive doses of thyroxine reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. J Clin Endocrinol Metab 1990;72:1184-1188.
20. Stall GM, Harris S, Sokoll LT, Dawson-Hughes B: Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med 1990;113:265-269.
21. Greenspan SL, Greenspan FS, Resnick NM, Block JE, Friedlander AI, Genant HK: Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy. Am J Med 1991;91:5-14.
22. Leese GP, Jung RT, Guthrie C, Waugh N, Browing MCK: Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH. Clin Endocrinol (Oxf) 1992;37:500-504.
23. De Menis E, Da Rio G, Roiter I, Legovini P, Foscolo G, Conte N: Bone turnover in overt and subclinical hyperthyroidism due to autonomous thyroid adenoma. Horm Res 1992;37: 217-220.
24. Sato K, Han DC, Fujii Y, Tsushima T, Shizume K: Thyroid hormone stimulates alkaline phosphatase activity in cultured rat osteoblastic cells(ROS 17/2.8) through 3,5,3́-triiodo-L-thyroxine nuclear receptors. Endocrinology 1987;120:1873-1881.
25. Kisakol G, Kaya A, Gonen S, Tune R: Bone and calcium metabolism in subclinical autoimmune hyperthyroidism and hypothyroidism. Endocr J 2003;50:657-661.
26. Vestergaard P, Mosekilde L: Hyperthyroidism, bone mineral, and fracture risk. A meta-analysis. Thyroid 2003;13:585-593.
27. Eriksen EF, Mosekilde L, Melsen F: Trabecular bone remodeling and bone balance in hyperthyroidism. Bone 1985;6:421-428.